Literature DB >> 26181604

Pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm: a report of 8 cases.

Koichiro Mandai1, Koji Uno2, Kenjiro Yasuda2.   

Abstract

Branch-duct intraductal papillary mucinous neoplasm (BD-IPMN) is recognized as a risk factor for pancreatic ductal adenocarcinoma (PDAC) that is unrelated to the malignant transformation of IPMN. We experienced 8 cases of resected PDAC concomitant with IPMN from March 1988 to December 2012, and 7 patients had >2 risk factors, including IPMN, for pancreatic cancer. Seven of the IPMNs were <30 mm in size, while none had mural nodules. Four cases of PDAC were detected during the follow-up period for BD-IPMN. Neither magnetic resonance cholangiopancreaticography nor contrast-enhanced computed tomography performed 5 months prior to the detection of PDAC resulted in its early detection in 2 cases. The clinical features of the 8 cases indicate that particular attention is required for patients with >1 risk factor, in addition to IPMN, for pancreatic cancer. A shorter interval of surveillance than that suggested by the international consensus guidelines 2012 is required, even if the IPMNs are small, for the early detection of PDAC.

Entities:  

Keywords:  Cancer; IPMN; PDAC; Pancreas

Year:  2013        PMID: 26181604     DOI: 10.1007/s12328-013-0386-x

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  16 in total

1.  Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan.

Authors:  Hiroyuki Maguchi; Satoshi Tanno; Nobumasa Mizuno; Keiji Hanada; Go Kobayashi; Takashi Hatori; Yoshihiko Sadakari; Taketo Yamaguchi; Kosuke Tobita; Ryuichiro Doi; Akio Yanagisawa; Masao Tanaka
Journal:  Pancreas       Date:  2011-04       Impact factor: 3.327

2.  Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN.

Authors:  Koji Yamaguchi; Shuichi Kanemitsu; Takashi Hatori; Hiroyuki Maguchi; Yasuhiro Shimizu; Minoru Tada; Toshio Nakagohri; Keiji Hanada; Manabu Osanai; Yutaka Noda; Akihiko Nakaizumi; Toru Furukawa; Shinichi Ban; Bunsei Nobukawa; Yo Kato; Masao Tanaka
Journal:  Pancreas       Date:  2011-05       Impact factor: 3.327

3.  Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Atsushi Kanno; Kennichi Satoh; Morihisa Hirota; Shin Hamada; Jun Umino; Hiromichi Itoh; Atsushi Masamune; Tohru Asakura; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2010-04-10       Impact factor: 7.527

4.  Staging of pancreatic carcinoma by endoscopic ultrasonography.

Authors:  K Yasuda; H Mukai; M Nakajima; K Kawai
Journal:  Endoscopy       Date:  1993-02       Impact factor: 10.093

5.  The revised Japanese clinical diagnostic criteria for chronic pancreatitis.

Authors:  Tooru Shimosegawa; Keisho Kataoka; Terumi Kamisawa; Hiroyuki Miyakawa; Hirotaka Ohara; Tetsuhide Ito; Satoru Naruse; Naohiro Sata; Koichi Suda; Morihisa Hirota; Yoshifumi Takeyama; Keiko Shiratori; Takashi Hatori; Makoto Otsuki; Yutaka Atomi; Kentaro Sugano; Masao Tanaka
Journal:  J Gastroenterol       Date:  2010-04-28       Impact factor: 7.527

6.  Clinicopathologic features of small pancreatic adenocarcinoma. A collective study.

Authors:  H Furukawa; S Okada; H Saisho; J Ariyama; E Karasawa; A Nakaizumi; S Nakazawa; K Murakami; T Kakizoe
Journal:  Cancer       Date:  1996-09-01       Impact factor: 6.860

7.  Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression.

Authors:  Dai Mohri; Yoshinari Asaoka; Hideaki Ijichi; Koji Miyabayashi; Yotaro Kudo; Motoko Seto; Miki Ohta; Motohisa Tada; Yasuo Tanaka; Tsuneo Ikenoue; Keisuke Tateishi; Hiroyuki Isayama; Fumihiko Kanai; Noriyoshi Fukushima; Minoru Tada; Takao Kawabe; Masao Omata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2011-11-01       Impact factor: 7.527

8.  Diagnostic significance of a dilated orifice of the duodenal papilla in intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Teppei Aso; Takao Ohtsuka; Noboru Ideno; Hiroshi Kono; Yosuke Nagayoshi; Yasuhisa Mori; Kennoki Ohuchida; Junji Ueda; Shunnichi Takahata; Katsuya Morimatsu; Shinichi Aishima; Hisato Igarashi; Tetsuhide Ito; Kousei Ishigami; Kazuhiro Mizumoto; Masao Tanaka
Journal:  Gastrointest Endosc       Date:  2012-05-31       Impact factor: 9.427

9.  Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Thun Ingkakul; Yoshihiko Sadakari; Jun Ienaga; Norihiro Satoh; Shunichi Takahata; Masao Tanaka
Journal:  Ann Surg       Date:  2010-01       Impact factor: 12.969

10.  Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging.

Authors:  M F Müller; C Meyenberger; P Bertschinger; R Schaer; B Marincek
Journal:  Radiology       Date:  1994-03       Impact factor: 11.105

View more
  1 in total

1.  Independent predictors of secondary invasive pancreatic remnant tumors after initial resection of an intraductal papillary mucinous neoplasm: a nationwide large-scale survey in Japan.

Authors:  Yutaka Takigawa; Minoru Kitago; Junichi Matsui
Journal:  Surg Today       Date:  2020-07-13       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.